ORSA
Venture capital · Marche-en-Famenne, Belgium · Europe
ORSA is an evergreen investment fund that finances and supports Walloon SMEs, formerly known as Investsud. It invests between €500,000 and €2,500,000 in equity or quasi-equity across development, transmission, buyout, biotech and startup/scale-up projects.
Invests inHealthcare & BiotechReal Estate & ConstructionEnterprise Software
Your fit with ORSA
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsORSA lists 4 checked portfolio companies on its own site and is named in 4 funding rounds. Its most frequent entry is Series A, 67% of the companies with a known first round. Its largest themes are Healthcare & Biotech (60%), Real Estate & Construction (20%) and Enterprise Software (20%). 75% of its companies are based in France. It invests most often alongside Noshaq, Angelor and Brick & Mortar Ventures.
Counts come from funding rounds that name ORSA, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 33% |
| Series A | 67% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 2 | 0 |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Noshaq | 3 |
| Angelor | 1 |
| Brick & Mortar Ventures | 1 |
| Creative Destruction Lab | 1 |
| Elaia | 1 |
| Invest.BW | 1 |
| Kurma Partners | 1 |
| Mission BioCapital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 60% | 15% |
| Real Estate & Construction | 20% | 3% |
| Enterprise Software | 20% | 8% |
Co-investor network
who it backs companies with, and who they back togetherCompare ORSA head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with ORSA| Date | Company | Stage |
|---|---|---|
| 20 Jul 2026 | Series A | |
| 8 Jan 2026 | Seed | |
| 25 Sept 2025 | Round | |
| 15 Jan 2025 | Series A |
Round details for ORSA
Amounts, full round histories and every co-investor in ORSA's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Brenus Pharma develops off-the-shelf immunotherapies for solid tumors | Healthcare & Biotech | Jul 2026Series A | Funding round | |
| Enodia Therapeutics develops novel small-molecule therapies for targeted protein degradation at the point of synthesis | Healthcare & Biotech | Jan 2026Seed | Funding round | |
| Trustup connects individuals with reliable professionals in the construction sector and provides a specialized software to help professionals develop their business and simplify administrative management. | Real Estate & ConstructionEnterprise Software | Jan 2025Series A | Funding round | |
| Sunrise develops and provides a sleep apnea test using mandibular jaw movements technology. | Healthcare & Biotech | Sept 2025Round | Funding round |
About this data
site last read 7 Nov 2026- Site
- orsafund.be
- Last read
- 7 Nov 2026
- Watching since
- 7 Nov 2026
- Rounds since
- 15 Jan 2025
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get ORSA's profile as data
Pull ORSA's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/orsafund.be
# also
GET /v1/firms/orsafund.be/portfolio
GET /v1/firms/orsafund.be/coinvestors
GET /v1/firms/orsafund.be/news